Our News on Newswise

Duke Clinical Research Institute launches long COVID trials through NIH RECOVER Long COVID Initiative

Today, the National Institutes of Health launched and is opening enrollment for phase 2 clinical trials that will evaluate at least four potential treatments for long COVID, with additional clinical trials to test at least seven more treatments...
31-Jul-2023 12:00 PM EDT Add to Favorites

Study Finds No Benefit to Taking Fluvoxamine for COVID-19 Symptoms

A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no symptomatic or clinical benefit to taking the antidepressant fluvoxamine 50 mg twice daily for 10 days for the treatment of...
19-Oct-2022 10:00 AM EDT Add to Favorites

At-Home COVID-19 Testing Programs Share How to Engage Diverse Communities in Public Health

Programs that distributed more than 2 million at-home COVID-19 tests to counties in North Carolina, Tennessee, and California with large underrepresented racial and ethnic populations were successful in getting test kits into the hands of community...
11-Oct-2022 10:05 AM EDT Add to Favorites

Duke to Co-Lead New Research Dissemination and Engagement Center to Help End Opioid Addiction

The Duke Clinical Research Institute (DCRI) will help establish a new nationwide center that will accelerate and expand the dissemination of the latest research on addiction and overdose to help communities devastated by the opioid crisis.
28-Sep-2022 12:00 PM EDT Add to Favorites

DCRI selected as Clinical Trials Data Coordinating Center for NIH RECOVER Long COVID Initiative

The Duke Clinical Research Institute (DCRI) has been named the Clinical Trials Data Coordinating Center for large-scale national research studies aimed at understanding and improving the treatment of long COVID.
2-Aug-2022 10:00 AM EDT Add to Favorites

Study Finds No Benefit to Taking Fluticasone Furoate for COVID-19 Symptoms

A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no symptomatic or clinical benefit to taking fluticasone furoate for the treatment of mild-to-moderate COVID-19 symptoms.
13-Jul-2022 10:05 AM EDT Add to Favorites

Study Finds No Benefit to Taking Ivermectin for COVID-19 Symptoms

A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no differences in relief of mild-to-moderate COVID-19 symptoms between participants taking ivermectin and participants taking a placebo.
13-Jun-2022 8:00 AM EDT Add to Favorites

Healthcare Workers Twice as Likely to Vaccinate Children Under 5 Immediately

Health care workers who have children under age 5 are twice as likely as other parents to plan to vaccinate their children against COVID-19, according to a new poll conducted by the HERO Registry, which is coordinated by the Duke Clinical Research...
24-Feb-2022 9:00 AM EST Add to Favorites


See All News

Our Experts on Newswise

Our experts are coming soon...

About

About section not configured. Is this your member page? Login to edit, or contact member@newswise.com to configure this module.

Experts

Contacts

Josee Meehan
Communications Specialist

josee.meehan@duke.edu

(919) 668-8813

Communications Team

echo_communications@dm.duke.edu

close
0.13366